As pressure-inhibition of GPIIb/IIIa may be beneficial in preventing capillary bed plugging [19, 20], inclined retention of the activated integrin after agonist exposure demonstrates a troubling adaptive possibility in which CKD patient platelets remain preferentially adherent for longer. Here, ITGA2B is linked to chronic kidney disease.